Status:
COMPLETED
Symptom Burden Guiding Invasive Electrophysiological Study in Paroxysmal Supraventricular Tachycardia
Lead Sponsor:
Hospital Universitario 12 de Octubre
Conditions:
Supraventricular Tachycardia
Eligibility:
All Genders
18+ years
Brief Summary
BELIEVE-SVT is a European multi-centre, retrospective registry in tertiary hospitals performing electrophysiological study in patients with palpitations considered clinically suggestive of paroxysmal ...
Detailed Description
The "Symptom Burden As Guiding Principle For Invasive Electrophysiological Study In Paroxysmal Supraventricular Tachycardia (Believe-SVT)" study was a multi-centre, retrospective, observational regist...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Symptoms that were considered suggestive of paroxysmal supraventricular tachycardia by a cardiologist and/or cardiac electrophysiologist
- Absence of any sort of ECG tracing during episodes (including wearables and other single lead devices)
- Exclusion criteria:
- Documentation of preexcitation
- Prior electrophysiological study aimed at the assessment of ventriculo-atrial conduction or induction of supraventricular tachycardias.
Exclusion
Key Trial Info
Start Date :
December 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
711 Patients enrolled
Trial Details
Trial ID
NCT06046352
Start Date
December 17 2019
End Date
June 1 2022
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario 12 de Octubre
Madrid, Spain, 28041